Protecting specific brain neurons from damage could be one way to treat or prevent Parkinson’s. Credit: National Institutes of Health
Scientists report that they have developed a novel compound that appears to protect mice against developing movement problems associated with Parkinson’s disease (PD).
The research, which could one day in the future translate into a therapy that could halt the progression of PD and thereby prevent the symptoms of the disease, appears in ACS’ Journal of Medicinal Chemistry.
Onyou Hwang, Ki Duk Park and colleagues explain that PD, which affects an estimated 4 million to 10 million people worldwide, is a progressive movement disorder with no known cure. It often starts with slight tremors and gets worse over time. Muscles go stiff. Walking becomes difficult. Speech is slurred. No one knows for certain what causes the disease, but research has shown that it’s linked with the loss of nerve cells in the brain that secrete dopamine, a chemical that is involved in movement and emotion. To find a potential new therapy for PD, the research team searched for a way to shield these brain cells.
They made 56 compounds and tested them to see which ones boosted the production of proteins that protect dopamine-releasing neurons from damage. Of those, one, which they call “12g,” proved to be the most active. Interestingly, it protected mice from developing PD-like symptoms in one laboratory test. “Taken together, 12g was found to effectively prevent the motor deficits that are associated with PD,” they say.
via The American Chemical Society
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- Physical activity levels, exercise habits may affect Parkinson’s outcomeson January 19, 2022 at 12:11 pm
High regular physical activity levels and exercise habits over time appeared significantly correlated with better outcomes in Parkinson’s disease, according to results of an observational cohort study ...
- Parkinson's progression may slow with four hours a week of exercise, study sayson January 19, 2022 at 8:00 am
For people with early-stage Parkinson’s disease, four hours a week of moderate exercise may help slow the progression of the disease.
- URI study aims to establish comprehensive Parkinson's clinicon January 19, 2022 at 7:59 am
One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- Is Parkinson’s Disease Curable? Research, Treatments, and Moreon January 19, 2022 at 3:17 am
Parkinson's disease can seriously impact your health and daily life. There's no cure yet, but research is always ongoing. Learn more.
- Study reveals a causal link between deficiency in Parkinson’s disease gene and reduced immunoagingon January 18, 2022 at 5:40 am
The latest findings in a study led by Dr Feng Hefeng at the Luxembourg Institute of Health’s (LIH) Immune Systems Biology Group could be just the tonic, having identified surprising age-defying ...
- Parkinson’s Disease Pipeline Offers Promising New Options for Treatment | DelveInsighton January 17, 2022 at 5:02 pm
DelveInsight’s “Parkinson’s Disease Pipeline Insight” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Parkinson’s Disease pipeline landscapes.Los Angeles, ...
- Exercise Slows Progression, Cognitive Decline in Early Parkinson'son January 17, 2022 at 12:19 pm
The study found moderate-to-vigorous exercise and even ordinary physical activity has a beneficial impact on slowing disease progression and cognitive decline in Parkinson's disease.
- Regular physical activity may help slow Parkinson's diseaseon January 13, 2022 at 8:16 am
A few hours of exercise a week may help slow Parkinson's disease, even if it's just moderate activity such as walking or gardening, a new study suggests.
- Examining how stress affects Parkinson’s diseaseon January 13, 2022 at 7:38 am
University of Cincinnati researchers have received a U.S. Department of Defense grant to further study how stress hormone receptors affect brain cell degeneration in Parkinson's disease.
via Bing News
